Press Enter to search · ESC to close

Macro

Novo Nordisk: Weight-Loss Drug Frehemgo Approved in Saudi Arabia, Under FDA Review

Novo Nordisk said its weight-loss drug Frehemgo has been approved in Saudi Arabia and is currently under review by the U.S. Food and Drug Administration and other regulators. The company disclosed the approval and the pending FDA review without giving a timeline for a U.S. decision. Frehemgo is Novo Nordisk’s weight-management treatment.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback